User profiles for Jaqueline G. de Jesus
Jaqueline Goes de JesusUniversidade de São Paulo Verified email at bahiana.edu.br Cited by 7089 |
Genomics and epidemiology of the P. 1 SARS-CoV-2 lineage in Manaus, Brazil
…, LAM Franco, MS Ramundo, JG De Jesus… - Science, 2021 - science.org
Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in
Manaus, Brazil, resurged in late 2020 despite previously high levels of infection. Genome …
Manaus, Brazil, resurged in late 2020 despite previously high levels of infection. Genome …
Evolution and epidemic spread of SARS-CoV-2 in Brazil
Brazil currently has one of the fastest-growing severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) epidemics in the world. Because of limited available data, assessments …
2 (SARS-CoV-2) epidemics in the world. Because of limited available data, assessments …
[HTML][HTML] Neutralisation of SARS-CoV-2 lineage P. 1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 …
Background Mutations accrued by SARS-CoV-2 lineage P.1—first detected in Brazil in early
January, 2021—include amino acid changes in the receptor-binding domain of the viral …
January, 2021—include amino acid changes in the receptor-binding domain of the viral …
[HTML][HTML] Genomic surveillance of yellow fever virus epizootic in São Paulo, Brazil, 2016–2018
…, L Du Plessis, PP Silveira, JG de Jesus… - PLoS …, 2020 - journals.plos.org
São Paulo, a densely inhabited state in southeast Brazil that contains the fourth most
populated city in the world, recently experienced its largest yellow fever virus (YFV) outbreak in …
populated city in the world, recently experienced its largest yellow fever virus (YFV) outbreak in …
Interacting epidemics in Amazonian Brazil: prior dengue infection associated with increased coronavirus disease 2019 (COVID-19) risk in a population-based cohort …
…, J Tonini, MA Cardoso, JG de Jesus… - Clinical Infectious …, 2021 - academic.oup.com
Background Immunity after dengue virus (DENV) infection has been suggested to cross-protect
from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and …
from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and …
[HTML][HTML] Rapid viral metagenomics using SMART-9N amplification and nanopore sequencing
…, ER Manuli, JG de Jesus, A de Paula… - Wellcome open …, 2021 - ncbi.nlm.nih.gov
Emerging and re-emerging viruses are a global health concern. Genome sequencing as an
approach for monitoring circulating viruses is currently hampered by complex and expensive …
approach for monitoring circulating viruses is currently hampered by complex and expensive …
Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples
…, DR Burton, LL Lewis-Ximenez, JG De Jesus… - Nature protocols, 2017 - nature.com
Genome sequencing has become a powerful tool for studying emerging infectious diseases;
however, genome sequencing directly from clinical samples (ie, without isolation and culture…
however, genome sequencing directly from clinical samples (ie, without isolation and culture…
[HTML][HTML] An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar
How viruses evolve within hosts can dictate infection outcomes; however, reconstructing
this process is challenging. We evaluate our multiplexed amplicon approach, PrimalSeq, to …
this process is challenging. We evaluate our multiplexed amplicon approach, PrimalSeq, to …
Nanopore native RNA sequencing of a human poly (A) transcriptome
High-throughput complementary DNA sequencing technologies have advanced our
understanding of transcriptome complexity and regulation. However, these methods lose …
understanding of transcriptome complexity and regulation. However, these methods lose …
[HTML][HTML] SARS-CoV-2 detection and culture in different biological specimens from immunocompetent and immunosuppressed COVID-19 patients infected with two …
Introduction—The dynamics of SARS-CoV-2 shedding and replication in humans remain
incompletely understood. Methods—We analyzed SARS-CoV-2 shedding from multiple sites in …
incompletely understood. Methods—We analyzed SARS-CoV-2 shedding from multiple sites in …